Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune ...
Here is a breakdown of the information In8bio, Inc. presented to its investors. IN8bio, Inc. is a clinical-stage biopharmaceutical company specializing in gamma-delta T cell-based immunotherapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback